Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:( pharmacodynamics). Showing records 1 – 30 of 264 total matches.

[1] [2] [3] [4] [5] [6] [7] [8] [9]

Search Limiters

Last 2 Years | English Only

Degrees

Levels

Languages

Country

▼ Search Limiters


University of Manchester

1. Jeans, Adam Rupert. The Pharmacodynamics of Antifungal Agents Against Aspergillus.

Degree: 2013, University of Manchester

 Background: Voriconazole is a first line agent for the treatment for invasive pulmonary aspergillosis. There are increasing reports of Aspergillus fumigatus isolates with reduced susceptibility… (more)

Subjects/Keywords: Aspergillus; Pharmacodynamics; Voriconazole; Anidulafungin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jeans, A. R. (2013). The Pharmacodynamics of Antifungal Agents Against Aspergillus. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:212715

Chicago Manual of Style (16th Edition):

Jeans, Adam Rupert. “The Pharmacodynamics of Antifungal Agents Against Aspergillus.” 2013. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:212715.

MLA Handbook (7th Edition):

Jeans, Adam Rupert. “The Pharmacodynamics of Antifungal Agents Against Aspergillus.” 2013. Web. 07 Aug 2020.

Vancouver:

Jeans AR. The Pharmacodynamics of Antifungal Agents Against Aspergillus. [Internet] [Doctoral dissertation]. University of Manchester; 2013. [cited 2020 Aug 07]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:212715.

Council of Science Editors:

Jeans AR. The Pharmacodynamics of Antifungal Agents Against Aspergillus. [Doctoral Dissertation]. University of Manchester; 2013. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:212715


University of Manchester

2. Felton, Timothy. Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach.

Degree: 2014, University of Manchester

Pulmonary infections in critically ill patients are common, frequently lethal and treatment may be complicated by bacterial resistance. Piperacillin-tazobactam (PTZ) is a broad-spectrum β-lactam antibiotic,… (more)

Subjects/Keywords: Pharmacokinetics; Pharmacodynamics; Piperacillin-tazobactam

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Felton, T. (2014). Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach. (Doctoral Dissertation). University of Manchester. Retrieved from http://www.manchester.ac.uk/escholar/uk-ac-man-scw:235681

Chicago Manual of Style (16th Edition):

Felton, Timothy. “Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach.” 2014. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. http://www.manchester.ac.uk/escholar/uk-ac-man-scw:235681.

MLA Handbook (7th Edition):

Felton, Timothy. “Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach.” 2014. Web. 07 Aug 2020.

Vancouver:

Felton T. Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach. [Internet] [Doctoral dissertation]. University of Manchester; 2014. [cited 2020 Aug 07]. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:235681.

Council of Science Editors:

Felton T. Antimicrobial therapy in critically ill patients: Improving clinical outcomes using a translational pharmacological approach. [Doctoral Dissertation]. University of Manchester; 2014. Available from: http://www.manchester.ac.uk/escholar/uk-ac-man-scw:235681


University of Adelaide

3. Licari, Giovanni. The stereoselective pharmacodynamics of the enantiomers of perhexiline.

Degree: 2013, University of Adelaide

 In the past decade there has been growing interest and evidence that altered myocardial energy metabolism plays a major role in the onset and/or progression… (more)

Subjects/Keywords: stereoselective; pharmacodynamics; enantiomers; perhexiline

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Licari, G. (2013). The stereoselective pharmacodynamics of the enantiomers of perhexiline. (Thesis). University of Adelaide. Retrieved from http://hdl.handle.net/2440/84991

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Licari, Giovanni. “The stereoselective pharmacodynamics of the enantiomers of perhexiline.” 2013. Thesis, University of Adelaide. Accessed August 07, 2020. http://hdl.handle.net/2440/84991.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Licari, Giovanni. “The stereoselective pharmacodynamics of the enantiomers of perhexiline.” 2013. Web. 07 Aug 2020.

Vancouver:

Licari G. The stereoselective pharmacodynamics of the enantiomers of perhexiline. [Internet] [Thesis]. University of Adelaide; 2013. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2440/84991.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Licari G. The stereoselective pharmacodynamics of the enantiomers of perhexiline. [Thesis]. University of Adelaide; 2013. Available from: http://hdl.handle.net/2440/84991

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Harvard University

4. Tanudra, Maria. Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations.

Degree: ALM, 2018, Harvard University

Infectious disease is one of the top ten leading causes of death worldwide (WHO, 2017). Emergence of new mechanisms of antibiotic resistance continually rises and… (more)

Subjects/Keywords: Hollow Fiber System; Pharmacokinetics/Pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Tanudra, M. (2018). Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations. (Masters Thesis). Harvard University. Retrieved from http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004045

Chicago Manual of Style (16th Edition):

Tanudra, Maria. “Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations.” 2018. Masters Thesis, Harvard University. Accessed August 07, 2020. http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004045.

MLA Handbook (7th Edition):

Tanudra, Maria. “Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations.” 2018. Web. 07 Aug 2020.

Vancouver:

Tanudra M. Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations. [Internet] [Masters thesis]. Harvard University; 2018. [cited 2020 Aug 07]. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004045.

Council of Science Editors:

Tanudra M. Leveraging the Dynamic in Vitro Hollow Fiber Infection Model in Determining Optimal Clinical Dose of β-Lactam and β-Lactamase Inhibitor Combinations. [Masters Thesis]. Harvard University; 2018. Available from: http://nrs.harvard.edu/urn-3:HUL.InstRepos:42004045


University of Manchester

5. Felton, Timothy. Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach.

Degree: PhD, 2014, University of Manchester

 Pulmonary infections in critically ill patients are common, frequently lethal and treatment may be complicated by bacterial resistance. Piperacillin-tazobactam (PTZ) is a broad-spectrum β-lactam antibiotic,… (more)

Subjects/Keywords: 615.1; Pharmacokinetics; Pharmacodynamics; Piperacillin-tazobactam

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Felton, T. (2014). Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/antimicrobial-therapy-in-critically-ill-patients-improving-clinical-outcomes-using-a-translational-pharmacological-approach(afffd886-c447-4974-ab0b-a9e8a8c8f2b2).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626967

Chicago Manual of Style (16th Edition):

Felton, Timothy. “Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach.” 2014. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. https://www.research.manchester.ac.uk/portal/en/theses/antimicrobial-therapy-in-critically-ill-patients-improving-clinical-outcomes-using-a-translational-pharmacological-approach(afffd886-c447-4974-ab0b-a9e8a8c8f2b2).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626967.

MLA Handbook (7th Edition):

Felton, Timothy. “Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach.” 2014. Web. 07 Aug 2020.

Vancouver:

Felton T. Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach. [Internet] [Doctoral dissertation]. University of Manchester; 2014. [cited 2020 Aug 07]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/antimicrobial-therapy-in-critically-ill-patients-improving-clinical-outcomes-using-a-translational-pharmacological-approach(afffd886-c447-4974-ab0b-a9e8a8c8f2b2).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626967.

Council of Science Editors:

Felton T. Antimicrobial therapy in critically ill patients : improving clinical outcomes using a translational pharmacological approach. [Doctoral Dissertation]. University of Manchester; 2014. Available from: https://www.research.manchester.ac.uk/portal/en/theses/antimicrobial-therapy-in-critically-ill-patients-improving-clinical-outcomes-using-a-translational-pharmacological-approach(afffd886-c447-4974-ab0b-a9e8a8c8f2b2).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.626967


University of Manchester

6. Jeans, Adam Rupert. The pharmacodynamics of antifungal agents against Aspergillus.

Degree: Thesis (M.D.), 2013, University of Manchester

 Background: Voriconazole is a first line agent for the treatment for invasive pulmonary aspergillosis. There are increasing reports of Aspergillus fumigatus isolates with reduced susceptibility… (more)

Subjects/Keywords: 615.7; Aspergillus; Pharmacodynamics; Voriconazole; Anidulafungin

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Jeans, A. R. (2013). The pharmacodynamics of antifungal agents against Aspergillus. (Doctoral Dissertation). University of Manchester. Retrieved from https://www.research.manchester.ac.uk/portal/en/theses/the-pharmacodynamics-of-antifungal-agents-against-aspergillus(42f0da51-46dc-4960-9912-d47e7871f496).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.607018

Chicago Manual of Style (16th Edition):

Jeans, Adam Rupert. “The pharmacodynamics of antifungal agents against Aspergillus.” 2013. Doctoral Dissertation, University of Manchester. Accessed August 07, 2020. https://www.research.manchester.ac.uk/portal/en/theses/the-pharmacodynamics-of-antifungal-agents-against-aspergillus(42f0da51-46dc-4960-9912-d47e7871f496).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.607018.

MLA Handbook (7th Edition):

Jeans, Adam Rupert. “The pharmacodynamics of antifungal agents against Aspergillus.” 2013. Web. 07 Aug 2020.

Vancouver:

Jeans AR. The pharmacodynamics of antifungal agents against Aspergillus. [Internet] [Doctoral dissertation]. University of Manchester; 2013. [cited 2020 Aug 07]. Available from: https://www.research.manchester.ac.uk/portal/en/theses/the-pharmacodynamics-of-antifungal-agents-against-aspergillus(42f0da51-46dc-4960-9912-d47e7871f496).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.607018.

Council of Science Editors:

Jeans AR. The pharmacodynamics of antifungal agents against Aspergillus. [Doctoral Dissertation]. University of Manchester; 2013. Available from: https://www.research.manchester.ac.uk/portal/en/theses/the-pharmacodynamics-of-antifungal-agents-against-aspergillus(42f0da51-46dc-4960-9912-d47e7871f496).html ; http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.607018


University of Gothenburg / Göteborgs Universitet

7. Henning, Matts, 1936-. Studies on the mode of action of î-methyldopa.

Degree: 1969, University of Gothenburg / Göteborgs Universitet

Subjects/Keywords: Methyldopa: pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Henning, Matts, 1. (1969). Studies on the mode of action of î-methyldopa. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/11600

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Henning, Matts, 1936-. “Studies on the mode of action of î-methyldopa.” 1969. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed August 07, 2020. http://hdl.handle.net/2077/11600.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Henning, Matts, 1936-. “Studies on the mode of action of î-methyldopa.” 1969. Web. 07 Aug 2020.

Vancouver:

Henning, Matts 1. Studies on the mode of action of î-methyldopa. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 1969. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2077/11600.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Henning, Matts 1. Studies on the mode of action of î-methyldopa. [Thesis]. University of Gothenburg / Göteborgs Universitet; 1969. Available from: http://hdl.handle.net/2077/11600

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Melbourne

8. Gwee, Amanda. Vancomycin pharmacokinetics and pharmacodynamics in young infants.

Degree: 2018, University of Melbourne

 Vancomycin is a glycopeptide antibiotic commonly used for the treatment of late-onset sepsis in young infants. Vancomycin dosing is challenging in young infants due to… (more)

Subjects/Keywords: vancomycin; glycopeptide; pharmacokinetics; pharmacodynamics; Staphylococcus

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gwee, A. (2018). Vancomycin pharmacokinetics and pharmacodynamics in young infants. (Doctoral Dissertation). University of Melbourne. Retrieved from http://hdl.handle.net/11343/221681

Chicago Manual of Style (16th Edition):

Gwee, Amanda. “Vancomycin pharmacokinetics and pharmacodynamics in young infants.” 2018. Doctoral Dissertation, University of Melbourne. Accessed August 07, 2020. http://hdl.handle.net/11343/221681.

MLA Handbook (7th Edition):

Gwee, Amanda. “Vancomycin pharmacokinetics and pharmacodynamics in young infants.” 2018. Web. 07 Aug 2020.

Vancouver:

Gwee A. Vancomycin pharmacokinetics and pharmacodynamics in young infants. [Internet] [Doctoral dissertation]. University of Melbourne; 2018. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11343/221681.

Council of Science Editors:

Gwee A. Vancomycin pharmacokinetics and pharmacodynamics in young infants. [Doctoral Dissertation]. University of Melbourne; 2018. Available from: http://hdl.handle.net/11343/221681


University of Manitoba

9. Calic, Divna. A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass.

Degree: Pharmacy, 2020, University of Manitoba

 Surgical site infections (SSI) following cardiac surgery result in significant patient morbidity and mortality. Antimicrobial prophylaxis (AP) with cefazolin is a core strategy for preventing… (more)

Subjects/Keywords: Pharmacokinetics; Pharmacodynamics; Cefazolin; Cardiac surgery

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Calic, D. (2020). A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass. (Thesis). University of Manitoba. Retrieved from http://hdl.handle.net/1993/34632

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Calic, Divna. “A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass.” 2020. Thesis, University of Manitoba. Accessed August 07, 2020. http://hdl.handle.net/1993/34632.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Calic, Divna. “A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass.” 2020. Web. 07 Aug 2020.

Vancouver:

Calic D. A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass. [Internet] [Thesis]. University of Manitoba; 2020. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/1993/34632.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Calic D. A pharmacokinetic/pharmacodynamic evaluation of cefazolin antimicrobial prophylaxis in cardiac surgery with cardiopulmonary bypass. [Thesis]. University of Manitoba; 2020. Available from: http://hdl.handle.net/1993/34632

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universiteit Utrecht

10. Keizer, R.J. Pharmacometrics in early clinical drug development.

Degree: 2010, Universiteit Utrecht

 Pharmacometrics, the science of quantitative clinical pharmacology, has been recognized as one of the main research fields able to improve efficiency in drug development, and… (more)

Subjects/Keywords: Farmacie; pharmacometrics; pharmacokinetics; pharmacodynamics; pharmacodynamics; drug development; oncology; cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Keizer, R. J. (2010). Pharmacometrics in early clinical drug development. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/179786

Chicago Manual of Style (16th Edition):

Keizer, R J. “Pharmacometrics in early clinical drug development.” 2010. Doctoral Dissertation, Universiteit Utrecht. Accessed August 07, 2020. http://dspace.library.uu.nl:8080/handle/1874/179786.

MLA Handbook (7th Edition):

Keizer, R J. “Pharmacometrics in early clinical drug development.” 2010. Web. 07 Aug 2020.

Vancouver:

Keizer RJ. Pharmacometrics in early clinical drug development. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2010. [cited 2020 Aug 07]. Available from: http://dspace.library.uu.nl:8080/handle/1874/179786.

Council of Science Editors:

Keizer RJ. Pharmacometrics in early clinical drug development. [Doctoral Dissertation]. Universiteit Utrecht; 2010. Available from: http://dspace.library.uu.nl:8080/handle/1874/179786


Temple University

11. Wang, Shining. DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS.

Degree: PhD, 2008, Temple University

Pharmaceutics

EGFR inhibitors, such as gefitinib, are examples of targeted anticancer drugs whose drug sensitivity is related to gene mutations that adds a pharmacogenetic [PG]… (more)

Subjects/Keywords: Health Sciences, Pharmacy; pharmacokinetics; pharmacodynamics; gefitinib; glioblastoma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wang, S. (2008). DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS. (Doctoral Dissertation). Temple University. Retrieved from http://digital.library.temple.edu/u?/p245801coll10,2535

Chicago Manual of Style (16th Edition):

Wang, Shining. “DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS.” 2008. Doctoral Dissertation, Temple University. Accessed August 07, 2020. http://digital.library.temple.edu/u?/p245801coll10,2535.

MLA Handbook (7th Edition):

Wang, Shining. “DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS.” 2008. Web. 07 Aug 2020.

Vancouver:

Wang S. DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS. [Internet] [Doctoral dissertation]. Temple University; 2008. [cited 2020 Aug 07]. Available from: http://digital.library.temple.edu/u?/p245801coll10,2535.

Council of Science Editors:

Wang S. DRUG DEVELOPMENT OF TARGETED ANTICANCER DRUGS BASED ON PK/PD INVESTIGATIONS. [Doctoral Dissertation]. Temple University; 2008. Available from: http://digital.library.temple.edu/u?/p245801coll10,2535


University of Otago

12. Wright, Daniel Frank. Model-based Drug Dosing .

Degree: 2013, University of Otago

 The safe and effective use of medicines requires that prescribers use the right drug for the right patient at the right dose. The choice of… (more)

Subjects/Keywords: warfarin; simvastatin; allopurinol; pharmacokinetics; pharmacodynamics; modelling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Wright, D. F. (2013). Model-based Drug Dosing . (Doctoral Dissertation). University of Otago. Retrieved from http://hdl.handle.net/10523/4398

Chicago Manual of Style (16th Edition):

Wright, Daniel Frank. “Model-based Drug Dosing .” 2013. Doctoral Dissertation, University of Otago. Accessed August 07, 2020. http://hdl.handle.net/10523/4398.

MLA Handbook (7th Edition):

Wright, Daniel Frank. “Model-based Drug Dosing .” 2013. Web. 07 Aug 2020.

Vancouver:

Wright DF. Model-based Drug Dosing . [Internet] [Doctoral dissertation]. University of Otago; 2013. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10523/4398.

Council of Science Editors:

Wright DF. Model-based Drug Dosing . [Doctoral Dissertation]. University of Otago; 2013. Available from: http://hdl.handle.net/10523/4398


University of Sydney

13. Kim, Hannah Yejin. Personalised Medicine in the Treatment of Cancer .

Degree: 2018, University of Sydney

 Understanding of pharmacokinetic-pharmacodynamic relationship for a given drug, and factors determining this, is an important part of personalised medicine in terms of choosing the correct… (more)

Subjects/Keywords: actinomycin D; dabrafenib; trametinib; pharmacokinetics; pharmacogenetics; pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kim, H. Y. (2018). Personalised Medicine in the Treatment of Cancer . (Thesis). University of Sydney. Retrieved from http://hdl.handle.net/2123/20103

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kim, Hannah Yejin. “Personalised Medicine in the Treatment of Cancer .” 2018. Thesis, University of Sydney. Accessed August 07, 2020. http://hdl.handle.net/2123/20103.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kim, Hannah Yejin. “Personalised Medicine in the Treatment of Cancer .” 2018. Web. 07 Aug 2020.

Vancouver:

Kim HY. Personalised Medicine in the Treatment of Cancer . [Internet] [Thesis]. University of Sydney; 2018. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2123/20103.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kim HY. Personalised Medicine in the Treatment of Cancer . [Thesis]. University of Sydney; 2018. Available from: http://hdl.handle.net/2123/20103

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Southern California

14. Chen, Xiaoying. Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics.

Degree: PhD, Pharmaceutical Sciences, 2011, University of Southern California

 Recombinant fusion proteins have become an important class of biomolecules since the invention of recombinant DNA technology. As an indispensable component of recombinant fusion proteins,… (more)

Subjects/Keywords: linker; fusion protein; transferrin; pharmacokinetics; pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Chen, X. (2011). Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics. (Doctoral Dissertation). University of Southern California. Retrieved from http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/637770/rec/3837

Chicago Manual of Style (16th Edition):

Chen, Xiaoying. “Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics.” 2011. Doctoral Dissertation, University of Southern California. Accessed August 07, 2020. http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/637770/rec/3837.

MLA Handbook (7th Edition):

Chen, Xiaoying. “Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics.” 2011. Web. 07 Aug 2020.

Vancouver:

Chen X. Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics. [Internet] [Doctoral dissertation]. University of Southern California; 2011. [cited 2020 Aug 07]. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/637770/rec/3837.

Council of Science Editors:

Chen X. Linkers in transferrin fusion proteins: effects on pharmacokinetics and pharmacodynamics. [Doctoral Dissertation]. University of Southern California; 2011. Available from: http://digitallibrary.usc.edu/cdm/compoundobject/collection/p15799coll127/id/637770/rec/3837


University of Gothenburg / Göteborgs Universitet

15. Hansson, Roland, 1948-. Postischemic renal damage : protective effects of free radical scavengers and allopurinol in rabbits.

Degree: 1983, University of Gothenburg / Göteborgs Universitet

Subjects/Keywords: Medicin Allmänt Allopurinol: pharmacodynamics; Free radicals: pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hansson, Roland, 1. (1983). Postischemic renal damage : protective effects of free radical scavengers and allopurinol in rabbits. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/11476

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hansson, Roland, 1948-. “Postischemic renal damage : protective effects of free radical scavengers and allopurinol in rabbits.” 1983. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed August 07, 2020. http://hdl.handle.net/2077/11476.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hansson, Roland, 1948-. “Postischemic renal damage : protective effects of free radical scavengers and allopurinol in rabbits.” 1983. Web. 07 Aug 2020.

Vancouver:

Hansson, Roland 1. Postischemic renal damage : protective effects of free radical scavengers and allopurinol in rabbits. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 1983. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2077/11476.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hansson, Roland 1. Postischemic renal damage : protective effects of free radical scavengers and allopurinol in rabbits. [Thesis]. University of Gothenburg / Göteborgs Universitet; 1983. Available from: http://hdl.handle.net/2077/11476

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Gothenburg / Göteborgs Universitet

16. Persson, Bengt, 1950-. GABAergic mechanisms in blood pressure control : a pharmacological analysis in the rat.

Degree: 1980, University of Gothenburg / Göteborgs Universitet

Subjects/Keywords: Medicin Allmänt Blood pressure: pharmacodynamics; GABA: pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Persson, Bengt, 1. (1980). GABAergic mechanisms in blood pressure control : a pharmacological analysis in the rat. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/13584

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Persson, Bengt, 1950-. “GABAergic mechanisms in blood pressure control : a pharmacological analysis in the rat.” 1980. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed August 07, 2020. http://hdl.handle.net/2077/13584.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Persson, Bengt, 1950-. “GABAergic mechanisms in blood pressure control : a pharmacological analysis in the rat.” 1980. Web. 07 Aug 2020.

Vancouver:

Persson, Bengt 1. GABAergic mechanisms in blood pressure control : a pharmacological analysis in the rat. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 1980. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2077/13584.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Persson, Bengt 1. GABAergic mechanisms in blood pressure control : a pharmacological analysis in the rat. [Thesis]. University of Gothenburg / Göteborgs Universitet; 1980. Available from: http://hdl.handle.net/2077/13584

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Gothenburg / Göteborgs Universitet

17. Volkmann, Reinhard, 1942-. Inverkan av katekolaminer och Ca++-antagonister på hjärtats elektromekaniska aktivitet = [Effects of catecholamines and calcium blockers on cardiac electrical and mechanical activities].

Degree: 1985, University of Gothenburg / Göteborgs Universitet

Subjects/Keywords: Medicin Allmänt Calcium channel blockers: pharmacodynamics; Catecholamines: pharmacodynamics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Volkmann, Reinhard, 1. (1985). Inverkan av katekolaminer och Ca++-antagonister på hjärtats elektromekaniska aktivitet = [Effects of catecholamines and calcium blockers on cardiac electrical and mechanical activities]. (Thesis). University of Gothenburg / Göteborgs Universitet. Retrieved from http://hdl.handle.net/2077/15008

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Volkmann, Reinhard, 1942-. “Inverkan av katekolaminer och Ca++-antagonister på hjärtats elektromekaniska aktivitet = [Effects of catecholamines and calcium blockers on cardiac electrical and mechanical activities].” 1985. Thesis, University of Gothenburg / Göteborgs Universitet. Accessed August 07, 2020. http://hdl.handle.net/2077/15008.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Volkmann, Reinhard, 1942-. “Inverkan av katekolaminer och Ca++-antagonister på hjärtats elektromekaniska aktivitet = [Effects of catecholamines and calcium blockers on cardiac electrical and mechanical activities].” 1985. Web. 07 Aug 2020.

Vancouver:

Volkmann, Reinhard 1. Inverkan av katekolaminer och Ca++-antagonister på hjärtats elektromekaniska aktivitet = [Effects of catecholamines and calcium blockers on cardiac electrical and mechanical activities]. [Internet] [Thesis]. University of Gothenburg / Göteborgs Universitet; 1985. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/2077/15008.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Volkmann, Reinhard 1. Inverkan av katekolaminer och Ca++-antagonister på hjärtats elektromekaniska aktivitet = [Effects of catecholamines and calcium blockers on cardiac electrical and mechanical activities]. [Thesis]. University of Gothenburg / Göteborgs Universitet; 1985. Available from: http://hdl.handle.net/2077/15008

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

18. Keizer, R.J. Pharmacometrics in early clinical drug development.

Degree: 2010, University Utrecht

 Pharmacometrics, the science of quantitative clinical pharmacology, has been recognized as one of the main research fields able to improve efficiency in drug development, and… (more)

Subjects/Keywords: pharmacometrics; pharmacokinetics; pharmacodynamics; pharmacodynamics; drug development; oncology; cancer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Keizer, R. J. (2010). Pharmacometrics in early clinical drug development. (Doctoral Dissertation). University Utrecht. Retrieved from https://dspace.library.uu.nl/handle/1874/179786 ; URN:NBN:NL:UI:10-1874-179786 ; urn:isbn:978-90-9025632-0 ; URN:NBN:NL:UI:10-1874-179786 ; https://dspace.library.uu.nl/handle/1874/179786

Chicago Manual of Style (16th Edition):

Keizer, R J. “Pharmacometrics in early clinical drug development.” 2010. Doctoral Dissertation, University Utrecht. Accessed August 07, 2020. https://dspace.library.uu.nl/handle/1874/179786 ; URN:NBN:NL:UI:10-1874-179786 ; urn:isbn:978-90-9025632-0 ; URN:NBN:NL:UI:10-1874-179786 ; https://dspace.library.uu.nl/handle/1874/179786.

MLA Handbook (7th Edition):

Keizer, R J. “Pharmacometrics in early clinical drug development.” 2010. Web. 07 Aug 2020.

Vancouver:

Keizer RJ. Pharmacometrics in early clinical drug development. [Internet] [Doctoral dissertation]. University Utrecht; 2010. [cited 2020 Aug 07]. Available from: https://dspace.library.uu.nl/handle/1874/179786 ; URN:NBN:NL:UI:10-1874-179786 ; urn:isbn:978-90-9025632-0 ; URN:NBN:NL:UI:10-1874-179786 ; https://dspace.library.uu.nl/handle/1874/179786.

Council of Science Editors:

Keizer RJ. Pharmacometrics in early clinical drug development. [Doctoral Dissertation]. University Utrecht; 2010. Available from: https://dspace.library.uu.nl/handle/1874/179786 ; URN:NBN:NL:UI:10-1874-179786 ; urn:isbn:978-90-9025632-0 ; URN:NBN:NL:UI:10-1874-179786 ; https://dspace.library.uu.nl/handle/1874/179786


University of Utah

19. LaPierre, Cristen Doyle. Identification of optimal dosing regimens for procedures requiring esophageal instrumentation through multiobjective optimization.

Degree: PhD, Bioengineering, 2010, University of Utah

 The use of propofol and propofol in combination with remifentanil by nonanesthesiologists is a controversial topic. Much of the concern centers on adverse respiratory effects:… (more)

Subjects/Keywords: Endoscopy; Multiobjective optimization; Optimal dosing; Pharmacodynamics; Propofol; Remifentanil

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

LaPierre, C. D. (2010). Identification of optimal dosing regimens for procedures requiring esophageal instrumentation through multiobjective optimization. (Doctoral Dissertation). University of Utah. Retrieved from http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/294/rec/1283

Chicago Manual of Style (16th Edition):

LaPierre, Cristen Doyle. “Identification of optimal dosing regimens for procedures requiring esophageal instrumentation through multiobjective optimization.” 2010. Doctoral Dissertation, University of Utah. Accessed August 07, 2020. http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/294/rec/1283.

MLA Handbook (7th Edition):

LaPierre, Cristen Doyle. “Identification of optimal dosing regimens for procedures requiring esophageal instrumentation through multiobjective optimization.” 2010. Web. 07 Aug 2020.

Vancouver:

LaPierre CD. Identification of optimal dosing regimens for procedures requiring esophageal instrumentation through multiobjective optimization. [Internet] [Doctoral dissertation]. University of Utah; 2010. [cited 2020 Aug 07]. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/294/rec/1283.

Council of Science Editors:

LaPierre CD. Identification of optimal dosing regimens for procedures requiring esophageal instrumentation through multiobjective optimization. [Doctoral Dissertation]. University of Utah; 2010. Available from: http://content.lib.utah.edu/cdm/singleitem/collection/etd3/id/294/rec/1283

20. 大島, 一浩. Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討.

Degree: 博士(医学), 2016, Nagasaki University / 長崎大学

 High-dose meropenem (MEPM; 6 g/day) has been approved as a treatment for purulent meningitis; however, little is known regarding its in vivo efficacy in refractory… (more)

Subjects/Keywords: high dose; meropenem; pharmacokinetics/pharmacodynamics; meropenem-resistant Pseudomonas aeruginosa

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

大島, . (2016). Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討. (Thesis). Nagasaki University / 長崎大学. Retrieved from http://hdl.handle.net/10069/37694

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

大島, 一浩. “Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討.” 2016. Thesis, Nagasaki University / 長崎大学. Accessed August 07, 2020. http://hdl.handle.net/10069/37694.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

大島, 一浩. “Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討.” 2016. Web. 07 Aug 2020.

Vancouver:

大島 . Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討. [Internet] [Thesis]. Nagasaki University / 長崎大学; 2016. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10069/37694.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

大島 . Efficacy of High-Dose Meropenem (6 g/day) in the Treatment of Experimental Murine Pneumonia Induced by Meropenem-resistant Pseudomonas aeruginosa : メロペネム耐性緑膿菌による肺炎に対する高用量メロペネム(6g/day)の効果の検討. [Thesis]. Nagasaki University / 長崎大学; 2016. Available from: http://hdl.handle.net/10069/37694

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

21. Oliveira, Juliana da Silva [UNESP]. Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu.

Degree: 2016, Universidade Estadual Paulista

Objetivos: Questionamentos têm sido lançados sobre a eficácia das formulações genéricas de vancomicina, empregadas com frequência nos países em desenvolvimento. No entanto, a grande disponibilidade… (more)

Subjects/Keywords: Vancomicina; Farmacocinética; Farmacodinâmica; Prognóstico; Vancomycin; Pharmacokinetics; Pharmacodynamics; Outcome

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Oliveira, J. d. S. [. (2016). Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu. (Thesis). Universidade Estadual Paulista. Retrieved from http://hdl.handle.net/11449/143843

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Oliveira, Juliana da Silva [UNESP]. “Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu.” 2016. Thesis, Universidade Estadual Paulista. Accessed August 07, 2020. http://hdl.handle.net/11449/143843.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Oliveira, Juliana da Silva [UNESP]. “Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu.” 2016. Web. 07 Aug 2020.

Vancouver:

Oliveira JdS[. Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu. [Internet] [Thesis]. Universidade Estadual Paulista; 2016. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/11449/143843.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Oliveira JdS[. Avaliação de Tecnologia em Saúde: fatores associados ao nível sérico de vancomicina e impacto do ajuste de dose sobre o prognóstico de pacientes adultos internados no Hospital das Clínicas da Faculdade de Medicina de Botucatu. [Thesis]. Universidade Estadual Paulista; 2016. Available from: http://hdl.handle.net/11449/143843

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

22. Rabi, Seyed rabi. MULTI-STEP INHIBITION EXPLAINS HIV-1 PROTEASE INHIBITOR PHARMACODYNAMICS AND RESISTANCE.

Degree: 2014, Johns Hopkins University

 HIV-1 protease inhibitors (PIs) are among the most effective antiretroviral drugs due to highly cooperative dose-response curves that are not explained by current pharmacodynamic theory.… (more)

Subjects/Keywords: HIV-1; Protease Inhibitor; multi-step; pharmacodynamics; dose-response curves

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Rabi, S. r. (2014). MULTI-STEP INHIBITION EXPLAINS HIV-1 PROTEASE INHIBITOR PHARMACODYNAMICS AND RESISTANCE. (Thesis). Johns Hopkins University. Retrieved from http://jhir.library.jhu.edu/handle/1774.2/36941

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Rabi, Seyed rabi. “MULTI-STEP INHIBITION EXPLAINS HIV-1 PROTEASE INHIBITOR PHARMACODYNAMICS AND RESISTANCE.” 2014. Thesis, Johns Hopkins University. Accessed August 07, 2020. http://jhir.library.jhu.edu/handle/1774.2/36941.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Rabi, Seyed rabi. “MULTI-STEP INHIBITION EXPLAINS HIV-1 PROTEASE INHIBITOR PHARMACODYNAMICS AND RESISTANCE.” 2014. Web. 07 Aug 2020.

Vancouver:

Rabi Sr. MULTI-STEP INHIBITION EXPLAINS HIV-1 PROTEASE INHIBITOR PHARMACODYNAMICS AND RESISTANCE. [Internet] [Thesis]. Johns Hopkins University; 2014. [cited 2020 Aug 07]. Available from: http://jhir.library.jhu.edu/handle/1774.2/36941.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Rabi Sr. MULTI-STEP INHIBITION EXPLAINS HIV-1 PROTEASE INHIBITOR PHARMACODYNAMICS AND RESISTANCE. [Thesis]. Johns Hopkins University; 2014. Available from: http://jhir.library.jhu.edu/handle/1774.2/36941

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

23. Δελής, Γεώργιος. Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο.

Degree: 2009, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ)

Amoxicillin (AMX), a semi-synthetic, broad-spectrum α-amino-p-hydroxybenzylpenicillin has been long used in veterinary medical practice for the treatment of bacterial respiratory, urinary, gastrointestinal, dermal, dental and… (more)

Subjects/Keywords: Αμοξικιλλίνη; Φαρμακοκινητική; Φαρμακοδυναμική; Συσχέτιση; Πρόβατα; Amoxicillin; Pharmacokinetics; Pharmacodynamics; Correlation; Sheeps

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Δελής, . . (2009). Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο. (Thesis). Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Retrieved from http://hdl.handle.net/10442/hedi/19233

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Δελής, Γεώργιος. “Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο.” 2009. Thesis, Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ). Accessed August 07, 2020. http://hdl.handle.net/10442/hedi/19233.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Δελής, Γεώργιος. “Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο.” 2009. Web. 07 Aug 2020.

Vancouver:

Δελής . Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο. [Internet] [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2009. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/10442/hedi/19233.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Δελής . Φαρμακοκινητική / φαρμακοδυναμική συσχέτιση της αμοξικιλλίνης στο πρόβατο. [Thesis]. Aristotle University Of Thessaloniki (AUTH); Αριστοτέλειο Πανεπιστήμιο Θεσσαλονίκης (ΑΠΘ); 2009. Available from: http://hdl.handle.net/10442/hedi/19233

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Kansas

24. Thomas, Sara R. Investigation of Microdialysis Sampling to Monitor Pharmacodynamics.

Degree: PhD, Chemistry, 2014, University of Kansas

 Microdialysis sampling is a technique commonly used to monitor a variety of processes in a tissue-targeted fashion. This sampling technique has several advantages over other… (more)

Subjects/Keywords: Chemistry; Chemobrain; Enzyme Activity; in vivo; Microdialysis; Pharmacodynamics; tissue-targeted sampling

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Thomas, S. R. (2014). Investigation of Microdialysis Sampling to Monitor Pharmacodynamics. (Doctoral Dissertation). University of Kansas. Retrieved from http://hdl.handle.net/1808/19604

Chicago Manual of Style (16th Edition):

Thomas, Sara R. “Investigation of Microdialysis Sampling to Monitor Pharmacodynamics.” 2014. Doctoral Dissertation, University of Kansas. Accessed August 07, 2020. http://hdl.handle.net/1808/19604.

MLA Handbook (7th Edition):

Thomas, Sara R. “Investigation of Microdialysis Sampling to Monitor Pharmacodynamics.” 2014. Web. 07 Aug 2020.

Vancouver:

Thomas SR. Investigation of Microdialysis Sampling to Monitor Pharmacodynamics. [Internet] [Doctoral dissertation]. University of Kansas; 2014. [cited 2020 Aug 07]. Available from: http://hdl.handle.net/1808/19604.

Council of Science Editors:

Thomas SR. Investigation of Microdialysis Sampling to Monitor Pharmacodynamics. [Doctoral Dissertation]. University of Kansas; 2014. Available from: http://hdl.handle.net/1808/19604


University of Cincinnati

25. Dave, Nimita D. Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole.

Degree: PhD, Pharmacy: Pharmaceutical Sciences/Biopharmaceutics, 2013, University of Cincinnati

 The lack of well-identified targets and limited access of drugs across the blood-brain and blood- tumor barriers are major impediments to the treatment of brain… (more)

Subjects/Keywords: Pharmaceuticals; pharmacokinetics; pharmacodynamics; letrozole; brain tumor; preclinical; glioma

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Dave, N. D. (2013). Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1368013158

Chicago Manual of Style (16th Edition):

Dave, Nimita D. “Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole.” 2013. Doctoral Dissertation, University of Cincinnati. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1368013158.

MLA Handbook (7th Edition):

Dave, Nimita D. “Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole.” 2013. Web. 07 Aug 2020.

Vancouver:

Dave ND. Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole. [Internet] [Doctoral dissertation]. University of Cincinnati; 2013. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1368013158.

Council of Science Editors:

Dave ND. Brain/Brain Tumor Pharmacokinetics and Pharmacodynamics of Letrozole. [Doctoral Dissertation]. University of Cincinnati; 2013. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1368013158


The Ohio State University

26. Aimiuwu, Josephine Eki. Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040.

Degree: PhD, Pharmacy, 2011, The Ohio State University

 Cancer, like most human diseases is complex and the therapeutic approaches available to treat this disease have limited efficacy. Therefore, combination studies of two or… (more)

Subjects/Keywords: Pharmaceuticals; preclinical; clinical pharmacokinetics/pharmacodynamics; and drug development

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Aimiuwu, J. E. (2011). Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040. (Doctoral Dissertation). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1292851882

Chicago Manual of Style (16th Edition):

Aimiuwu, Josephine Eki. “Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040.” 2011. Doctoral Dissertation, The Ohio State University. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1292851882.

MLA Handbook (7th Edition):

Aimiuwu, Josephine Eki. “Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040.” 2011. Web. 07 Aug 2020.

Vancouver:

Aimiuwu JE. Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040. [Internet] [Doctoral dissertation]. The Ohio State University; 2011. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1292851882.

Council of Science Editors:

Aimiuwu JE. Modulation of Pharmacologic Effects of 5-Azacytidine by Ribonucleotide Reductase Antisense GTI-2040. [Doctoral Dissertation]. The Ohio State University; 2011. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1292851882


The Ohio State University

27. Cober, Richard E. Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats.

Degree: MS, Veterinary Clinical Sciences, 2010, The Ohio State University

 Heart rate is one of the main determinants of ischemia, a pathophysiologic characteristic of hypertrophic cardiomyopathy (HCM). Unwanted tachycardia may trigger decompensation in previously asymptomatic… (more)

Subjects/Keywords: Animals; Veterinary Services; Ivabradine; Heart Rate; Pharmacodynamics; If inhibitor

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Cober, R. E. (2010). Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats. (Masters Thesis). The Ohio State University. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=osu1272998433

Chicago Manual of Style (16th Edition):

Cober, Richard E. “Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats.” 2010. Masters Thesis, The Ohio State University. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=osu1272998433.

MLA Handbook (7th Edition):

Cober, Richard E. “Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats.” 2010. Web. 07 Aug 2020.

Vancouver:

Cober RE. Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats. [Internet] [Masters thesis]. The Ohio State University; 2010. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1272998433.

Council of Science Editors:

Cober RE. Effects of Ivabradine, A New Selective If Current Inhibitor, on Heart Rate in Cats. [Masters Thesis]. The Ohio State University; 2010. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=osu1272998433


University of Cincinnati

28. Samineni, Divya. Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin.

Degree: PhD, Pharmacy: Pharmaceutical Sciences/Biopharmaceutics, 2011, University of Cincinnati

  Treatment of dyslipidemia in HIV-infected persons is commonly required with the use of protease inhibitors (PIs) which may be restricted by drug-drug interactions between… (more)

Subjects/Keywords: Pharmaceuticals; Pharmacokinetics; Pharmacodynamics; Pharmacogenomics; Rosuvastatin; Darunavir; OATP1B1 Uptake

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Samineni, D. (2011). Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin. (Doctoral Dissertation). University of Cincinnati. Retrieved from http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314040722

Chicago Manual of Style (16th Edition):

Samineni, Divya. “Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin.” 2011. Doctoral Dissertation, University of Cincinnati. Accessed August 07, 2020. http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314040722.

MLA Handbook (7th Edition):

Samineni, Divya. “Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin.” 2011. Web. 07 Aug 2020.

Vancouver:

Samineni D. Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin. [Internet] [Doctoral dissertation]. University of Cincinnati; 2011. [cited 2020 Aug 07]. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314040722.

Council of Science Editors:

Samineni D. Pre-Clinical and Clinical Investigation of Pharmacokinetic and Pharmacodynamic Interactions between Darunavir, a Novel Protease Inhibitor and Rosuvastatin. [Doctoral Dissertation]. University of Cincinnati; 2011. Available from: http://rave.ohiolink.edu/etdc/view?acc_num=ucin1314040722


Universiteit Utrecht

29. Zandvliet, A.S. Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam.

Degree: 2007, Universiteit Utrecht

 Indisulam is an investigational anticancer agent that is currently being evaluated in phase II clinical studies. The aim of this thesis was to develop a… (more)

Subjects/Keywords: Farmacie; pharmacokinetics; pharmacodynamics; indisulam; modeling; simulation; clinical; oncology; pharmacology; myelosuppression; neutropenia

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Zandvliet, A. S. (2007). Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/22763

Chicago Manual of Style (16th Edition):

Zandvliet, A S. “Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam.” 2007. Doctoral Dissertation, Universiteit Utrecht. Accessed August 07, 2020. http://dspace.library.uu.nl:8080/handle/1874/22763.

MLA Handbook (7th Edition):

Zandvliet, A S. “Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam.” 2007. Web. 07 Aug 2020.

Vancouver:

Zandvliet AS. Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2007. [cited 2020 Aug 07]. Available from: http://dspace.library.uu.nl:8080/handle/1874/22763.

Council of Science Editors:

Zandvliet AS. Population pharmacokinetic and pharmacodynamic modeling and simulation of the investigational anticancer agent indisulam. [Doctoral Dissertation]. Universiteit Utrecht; 2007. Available from: http://dspace.library.uu.nl:8080/handle/1874/22763


Universiteit Utrecht

30. Klümpen, H.J. Personalized medicine of targeted anti-cancer drugs.

Degree: 2012, Universiteit Utrecht

 Medicine is becoming more and more tailored and that certainly applies to therapies for cancer. The researcher has looked at the genetic profile of the… (more)

Subjects/Keywords: Farmacie; pharmacogenetics; pharmacodynamics; targeted therapies; mTOR inhibitors; imatinib; sunitinib

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Klümpen, H. J. (2012). Personalized medicine of targeted anti-cancer drugs. (Doctoral Dissertation). Universiteit Utrecht. Retrieved from http://dspace.library.uu.nl:8080/handle/1874/234354

Chicago Manual of Style (16th Edition):

Klümpen, H J. “Personalized medicine of targeted anti-cancer drugs.” 2012. Doctoral Dissertation, Universiteit Utrecht. Accessed August 07, 2020. http://dspace.library.uu.nl:8080/handle/1874/234354.

MLA Handbook (7th Edition):

Klümpen, H J. “Personalized medicine of targeted anti-cancer drugs.” 2012. Web. 07 Aug 2020.

Vancouver:

Klümpen HJ. Personalized medicine of targeted anti-cancer drugs. [Internet] [Doctoral dissertation]. Universiteit Utrecht; 2012. [cited 2020 Aug 07]. Available from: http://dspace.library.uu.nl:8080/handle/1874/234354.

Council of Science Editors:

Klümpen HJ. Personalized medicine of targeted anti-cancer drugs. [Doctoral Dissertation]. Universiteit Utrecht; 2012. Available from: http://dspace.library.uu.nl:8080/handle/1874/234354

[1] [2] [3] [4] [5] [6] [7] [8] [9]

.